The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.
Kalliokoski RJ, Kantola I, Kalliokoski KK, Engblom E, Sundell J, Hannukainen JC, Janatuinen T, Raitakari OT, Knuuti J, Penttinen M, Viikari J, Nuutila P.
Kalliokoski RJ, et al. Among authors: engblom e.
J Inherit Metab Dis. 2006 Feb;29(1):112-8. doi: 10.1007/s10545-006-0221-3.
J Inherit Metab Dis. 2006.
PMID: 16601877
Clinical Trial.